The Philippines is aiming to conclude this week negotiations with China’s Sinovac Biotech to acquire 25 million doses of the company’s vaccine for the coronavirus disease 2019 (Covid-19), and deliver the stocks for March next year.
“We have already conveyed to them our needs, 25 million for 2021,” Carlito Galvez, the country’s vaccine chief, said.
Philippine officials had met with Sinovac representatives on Friday and there would be another meeting this week to finalize a deal, Galvez added.
Palace Spokesperson Harry Roque told the news conference that compared to Covid-19 vaccines from Western vaccine brands, “the Chinese brand will come earlier.”
Besides Sinovac, three other Chinese firms are developing their Covid-19 vaccines.
Besides Sinovac, the Philippines is eyeing Covid-19 vaccines from AstraZeneca and Pfizer.
The private sector has already concluded an agreement with AstraZeneca for the purchase of at least 2.6 million doses of its Covid-19 vaccines. The stocks will be paid for by the private sector, amounting to around P626 million. SOVEREIGNPH